Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation Plus Stenting Versus Stenting Alone for Treatment of Malignant Biliary Obstruction

NCT03166436 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT03166436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03166436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation Plus Stenting Versus Stenting Alone for Treatment of Malignant Biliary Obstruction
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
June 8, 2017
Completion date
May 8, 2020
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, pancreas cancer